291 related articles for article (PubMed ID: 21102582)
1. Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells.
Watanabe T; Semba S; Yokozaki H
Br J Cancer; 2011 Jan; 104(1):146-54. PubMed ID: 21102582
[TBL] [Abstract][Full Text] [Related]
2. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
Xiong B; Cheng Y; Ma L; Zhang C
Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
4. Brg1-dependent epigenetic control of vascular smooth muscle cell proliferation by hydrogen sulfide.
Li L; Liu D; Bu D; Chen S; Wu J; Tang C; Du J; Jin H
Biochim Biophys Acta; 2013 Jun; 1833(6):1347-55. PubMed ID: 23499876
[TBL] [Abstract][Full Text] [Related]
5. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
9. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
10. Brahma is required for cell cycle arrest and late muscle gene expression during skeletal myogenesis.
Albini S; Coutinho Toto P; Dall'Agnese A; Malecova B; Cenciarelli C; Felsani A; Caruso M; Bultman SJ; Puri PL
EMBO Rep; 2015 Aug; 16(8):1037-50. PubMed ID: 26136374
[TBL] [Abstract][Full Text] [Related]
11. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
[TBL] [Abstract][Full Text] [Related]
12. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
[TBL] [Abstract][Full Text] [Related]
13. Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer.
Ding Y; Li N; Dong B; Guo W; Wei H; Chen Q; Yuan H; Han Y; Chang H; Kan S; Wang X; Pan Q; Wu P; Peng C; Qiu T; Li Q; Gao D; Xue W; Qin J
J Clin Invest; 2019 Feb; 129(2):759-773. PubMed ID: 30496141
[TBL] [Abstract][Full Text] [Related]
14. BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes.
Sena JA; Wang L; Hu CJ
Mol Cell Biol; 2013 Oct; 33(19):3849-63. PubMed ID: 23897427
[TBL] [Abstract][Full Text] [Related]
15. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.
Marty B; Maire V; Gravier E; Rigaill G; Vincent-Salomon A; Kappler M; Lebigot I; Djelti F; Tourdès A; Gestraud P; Hupé P; Barillot E; Cruzalegui F; Tucker GC; Stern MH; Thiery JP; Hickman JA; Dubois T
Breast Cancer Res; 2008; 10(6):R101. PubMed ID: 19055754
[TBL] [Abstract][Full Text] [Related]
16. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
[TBL] [Abstract][Full Text] [Related]
17. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.
Naidu SR; Love IM; Imbalzano AN; Grossman SR; Androphy EJ
Oncogene; 2009 Jul; 28(27):2492-501. PubMed ID: 19448667
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.
Mehrotra A; Saladi SV; Trivedi AR; Aras S; Qi H; Jayanthy A; Setaluri V; de la Serna IL
Arch Biochem Biophys; 2014 Dec; 563():125-35. PubMed ID: 25026375
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway.
Shi H; Chen S; Jin H; Xu C; Dong G; Zhao Q; Wang W; Zhang H; Lin W; Zhang J; Davidovic L; Yao L; Fan D
Cancer Sci; 2009 Sep; 100(9):1585-90. PubMed ID: 19549253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
